Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Scientific Conference: 30 Years of Research

26/11/2024

Vall d'Hebron Talks by VHIR 'The anemia-transfusion dilemma: effects of prolonged storage on red blood cell’s osmotic fragility and morphology'
Ubicació
Sala d’actes de la planta baixa de l’Hospital General
Etiqueta
Vall d'Hebron Talks by VHIR
26/11/2024

Sessió '‘Ciència Ciutadana en salut: perspectiva internacional, el paper de pacients i passos endavant a Catalunya'
Ubicació
Boardroom of the VHIR Edifici Central (Floor 0)
Etiqueta
Jornades
14/11/2024

VII Jornada d'Assessorament Genètic. Avanços i desafiaments a l'assessorament genètic reproductiu
Ubicació
Sala d’actes de la planta 10 de l’Hospital General
Etiqueta
Jornades
08/11/2024

Defensa de Tesi 'Sex-based modulation of neuromelanin-linked Parkinson's disease pathology'
Ubicació
Sala d’actes de la planta baixa de l’Hospital General
Etiqueta
Tesis
14/11/2024

6a Edició Jo Innovo
Etiqueta
Jornades
11/11/2024

Setmana de la Innovació
Ubicació
Sala d’actes de la planta 10 de l’Hospital General
Etiqueta
Jornades

Estudio Basket multicéntrico, aleatorizado, doble ciego, controlado con placebo, de 52 semanas de duración y con una extensión abierta para investigar la eficacia, seguridad y tolerabilidad de remibrutinib (LOU064) en urticaria crónica inducible (CINDU) en adultos inadecuadamente controlada con antihistamínicos H1.

Contact
  • Protocol code: CLOU064M12301
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Labrador Horrillo, Moisés
  • Research group:  Malalties sistèmiques
  • Service: Medicina Interna
  • Phase: Fase III
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Ensayo de fase IIb, multicéntrico, aleatorizado, con doble enmascaramiento, en el que se evalúa la microbioterapia fecal combinada oral MaaT033 para prevenir las complicaciones del alotrasplante de células hematopoyéticas

Contact
  • Protocol code: MPOH08
  • EudraCT code: No aplica
  • Pathology: Tumors
  • Principal investigator:  Sola Soto, Maria
  • Service: Hematologia i Hematoteràpia
  • Phase: Fase II
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Eficacia y seguridad de la tirzepatida administrada una vez a la semana en comparación con un placebo en el tratamiento de la obesidad y enfermedades asociadas con el peso en adolescentes; estudio aleatorizado, con enmascaramiento doble y comparativo con un placebo

Contact
  • Protocol code: I8F-MC-GPIX
  • EudraCT code: No aplica
  • Pathology: Malalties endocrines, nutricionals i metabòliques
  • Principal investigator:  Ciudin Mihai, Andreea
  • Research group:  Diabetis i metabolisme
  • Service: Endocrinologia
  • Phase: Fase III
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Subscribe to